J Exp Clin Cancer Res. 2020; 39: 100. Published online 2020 Jun 3. doi: 10.1186/s13046-020-01584-0

Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells

Kenly Wuputra,^1,2 Chia-Chen Ku,^1,2 Deng-Chyang Wu,^2,3 Ying-Chu Lin,⁴ Shigeo Saito, ^5,6 and Kazunari K. Yokoyama ^1,2,5

Abstract

Human pluripotent embryonic stem cells have two special features: self-renewal and pluripotency. It is important to understand the properties of pluripotent stem cells and reprogrammed stem cells. One of the major problems is the risk of reprogrammed stem cells developing into tumors. To understand the process of differentiation through which stem cells develop into cancer cells, investigators have attempted to identify the key factors that generate tumors in humans. The most effective method for the prevention of tumorigenesis is the exclusion of cancer cells during cell reprogramming. The risk of cancer formation is dependent on mutations of oncogenes and tumor suppressor genes during the conversion of stem cells to cancer cells and on the environmental effects of pluripotent stem cells. Dissecting the processes of epigenetic regulation and chromatin regulation may be helpful for achieving correct cell reprogramming without inducing tumor formation and for developing new drugs for cancer treatment. This review focuses on the risk of tumor formation by human pluripotent stem cells, and on the possible treatment options if it occurs. Potential new techniques that target epigenetic processes and chromatin regulation provide opportunities for human cancer modeling and clinical applications of regenerative medicine.